Galapagos NV
GLPG
#4564
Rank
HK$16.45 B
Marketcap
HK$246.12
Share price
0.44%
Change (1 day)
18.22%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -HK$4.16 Billion

According to Galapagos NV's latest financial reports the company's current earnings are HK$0.32 Billion. In 2024 the company made an earning of -HK$44.97 Million, an increase over its 2023 earnings that were of -HK$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$4.16 Billion9132.71%
2024 -HK$44.97 Million-82.77%
2023 -HK$0.27 Billion-85.59%
2022 -HK$1.82 Billion60.71%
2021 -HK$1.13 Billion-60.08%
2020 -HK$2.83 Billion-331.44%
2019 HK$1.22 B-523.76%
2018 -HK$0.29 Billion-72.34%
2017 -HK$1.05 Billion-329.59%
2016 HK$0.45 B-144.3%
2015 -HK$1.03 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
HK$101.85 B-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
HK$252.07 B-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$70.81 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
HK$12.91 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-HK$0.7 Billion-83.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$63.32 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$13.78 B-432.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
HK$72.54 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$179.66 B-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA